CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients

Link to the original source: https://www.nature.com/articles/s41423-019-0275-4

APA: Vitallé, J; Terrén, I; Orrantia, A; Pérez-Garay, R; Vidal, F; Iribarren, JA; Rodríguez, C; Lirola, AML; Bernal, E; Zenarruzabeitia, O; Borrego, F (2019). CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients. Cellular & Molecular Immunology, 16(12), 940-942. DOI: 10.1038/s41423-019-0275-4

Paper original source: Cellular & Molecular Immunology. 16 (12): 940-942

Article's DOI: 10.1038/s41423-019-0275-4

Journal publication year: 2019-12-01

Entity: Universitat Rovira i Virgili

Paper version: info:eu-repo/semantics/publishedVersion

Record's date: 2026-05-09

URV's Author/s: Vidal Marsal, Francisco

Department: Medicina i Cirurgia

Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/

Publication Type: Journal Publications

ISSN: 16727681

Author, as appears in the article.: Vitallé, J; Terrén, I; Orrantia, A; Pérez-Garay, R; Vidal, F; Iribarren, JA; Rodríguez, C; Lirola, AML; Bernal, E; Zenarruzabeitia, O; Borrego, F

licence for use: https://creativecommons.org/licenses/by/3.0/es/

Thematic Areas: Medicine (miscellaneous), Infectious diseases, Immunology and allergy, Immunology, Ciências biológicas i

Author's mail: francesc.vidal@urv.cat, francesc.vidal@urv.cat